Evaluation of clinical application of transjugular liver biopsy in 61 cases
10.3760/cma.j.cn501113-20190909-00328
- VernacularTitle:61例经颈静脉肝脏穿刺活组织检查术临床应用的评价
- Author:
Guanhua ZHANG
1
;
Min WANG
;
Guang CHEN
;
Jian'an YU
;
Hong MA
;
Xiaojuan OU
;
Yu WANG
Author Information
1. 首都医科大学附属北京友谊医院肝病中心 国家消化系统疾病临床医学研究中心 100050
- Keywords:
Liver diseases;
Liver biopsy, transjugular;
Quality of specimen;
Complications
- From:
Chinese Journal of Hepatology
2020;28(11):949-953
- CountryChina
- Language:Chinese
-
Abstract:
Objective:To evaluate the effectiveness and safety of transjugular liver biopsy (TJLB) in clinical applications.Methods:Clinical data of patients who underwent TJLB in the Beijing Friendship Hospital Affiliated to Capital Medical University from November 2017 to March 2019 were retrospectively reviewed. Clinical characteristics, indications and biopsy complications and the samples quality were analyzed.Results:Among 61 cases who underwent TJLB, 32 were males and 29 were females, aged 16 to 79 years. There were 43 cases (70.5%) with abnormal coagulation function, among which the prothrombin time activity percentage (39%) and platelet count (24×10 9/L ) were lowest. 38 cases (62.3%) had perihepatic fluid. One case was obese, and had a body mass index of 31kg/m2. 56 cases (91.8%) were successfully biopsied. 51 cases (83.6%) liver tissue samples were assessed with pathological diagnosis. Five cases (8.2%) had serious complications. 14 cases (23.0%) had mild complications, and no patients died. Conclusion:TJLB is a safe and feasible method for patients who have contraindications to percutaneous liver biopsy.
